Amir Toporik
28Patents
7h-index
63Co-inventors
68Inventor score
Filing activity: Jan 27, 2005 → Jan 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7368548B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer | Chemistry; Metallurgy | 78 | Expired |
| US7667001B1 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | Chemistry; Metallurgy | 76 | Active |
| US7569662B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | Chemistry; Metallurgy | 75 | Expired |
| US9409987B2 | Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer | Emerging Cross-Sectional Technologies | 19 | Active |
| US8492329B2 | Bioactive peptides and methods of using same | Emerging Cross-Sectional Technologies | 15 | Active |
| US7345142B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease | Physics | 13 | Expired |
| US8529943B2 | Angiopoietin derived peptides | Chemistry; Metallurgy | 10 | Active |
| US7842459B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis | Chemistry; Metallurgy | 5 | Active |
| US8415455B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 5 | Active |
| US7553948B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer | Chemistry; Metallurgy | 5 | Active |
| US7939634B2 | Polynucleotides encoding polypeptides and methods using same | Emerging Cross-Sectional Technologies | 5 | Active |
| US9107862B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US9375466B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US7714100B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease | Physics | 3 | Active |
| US7601692B2 | MCP-1 splice variants and methods of using same | Chemistry; Metallurgy | 2 | Active |
| US7884180B2 | Peptides which bind to G protein-coupled receptors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10550173B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 1 | Active |
| US10098934B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 1 | Active |
| US7906635B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US7528243B2 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer | Chemistry; Metallurgy | 1 | Active |
| US8349801B2 | Peptide ligands for G-protein coupled receptors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9555087B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 1 | Active |
| US9428574B2 | Polypeptides and uses thereof for treatment of autoimmune disorders and infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US8828940B2 | Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands | Emerging Cross-Sectional Technologies | 0 | Active |
| US9255132B2 | Angiopoietin derived peptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.